Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03554915 · ClinicalTrials.gov registry record
Ketamine Versus Midazolam for Prehospital Agitation
A clinical trial, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- 314
- Enrollment target
NCT03554915 is a clinical trial that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 314 participants.
The verdict
NCT03554915 has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- 314 participants
- Enrollment target
Study Summary
This research study is being done to figure out the best approach to treatment of pre-hospital agitation. It will compare two tiered dosing treatment protocols, one ketamine-based and one midazolam-based. Agitation is a state of extreme emotional disturbance where patients can become physically aggressive or violent, endangering themselves and those who are caring for them. Often chemical substances or severe mental illness are involved in this level of agitation. Specifically, the investigators are interested in studying agitation that is treated in the prehospital setting by paramedics. This study's hypothesis is a ketamine-based protocol will achieve a faster time to adequate sedation than a midazolam-based protocol for treatment of agitation in the prehospital environment. This study will observe the natural history of an emergency medical services standard operating procedure change from a ketamine-based protocol to a midazolam-based protocol.
Interventions
- OTHER Ketamine-based protocol
- OTHER Midazolam-based protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2018-09-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03554915
The ClinicalTrials.gov registry entry for NCT03554915 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 314 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine-based protocol is the first listed.
NCT03554915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03554915 about?
NCT03554915 is a clinical study titled "Ketamine Versus Midazolam for Prehospital Agitation". This research study is being done to figure out the best approach to treatment of pre-hospital agitation. It will compare two tiered dosing treatment protocols, one ketamine-based and one midazolam-based. Agitation is a state of extreme emotional disturbance where patients can become physically aggr...
What is the current status of trial NCT03554915?
This trial is currently completed. The enrollment target is 314 participants. The study started on 2017-08-01. Estimated completion is 2018-09-24.
What interventions are being tested in trial NCT03554915?
The interventions under investigation include: Ketamine-based protocol (OTHER), Midazolam-based protocol (OTHER).
Who is sponsoring clinical trial NCT03554915?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.